Olwen Hahn to Combined Modality Therapy
This is a "connection" page, showing publications Olwen Hahn has written about Combined Modality Therapy.
Connection Strength
0.080
-
Validation of the RSClin risk calculator in the National Cancer Data Base. Cancer. 2024 Apr 15; 130(8):1210-1220.
Score: 0.044
-
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors. Clin Cancer Res. 2021 10 15; 27(20):5510-5518.
Score: 0.037